Company / Gross Profit per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.15
FY2025
5-year range
$0.13 / $0.29
FY2021-FY2025
Trend
+18.0%
vs FY2024
Sector context
#98 of 99
Health Care
What the data says
Among 99 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 1% for gross profit per share. Gross Profit per Share returned to growth in FY2025 after 3 years of decline, reaching $0.15.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of -3.9%.
Declined from $0.21 to $0.15 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 99This company $0.15 Sector average $13.98
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 18.0% year-over-year.
- Ranks #98 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2016.
- Lowest gross profit per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | +18.0% |
| FY2024 | $0.13 | -37.9% |
| FY2023 | $0.21 | -4.7% |
| FY2022 | $0.22 | -24.3% |
| FY2021 | $0.29 | +54.9% |
| FY2020 | $0.19 | -17.9% |
| FY2019 | $0.23 | +5.0% |
| FY2018 | $0.22 | -42.3% |
| FY2017 | $0.37 | -32.3% |
| FY2016 | $0.55 | +535.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026